Abstract
Background
The co-circulation of flaviviruses in tropical regions has led to the hypothesis that immunity generated by a previous dengue infection could promote severe disease outcomes in subsequent infections by heterologous serotypes. This study investigated the influence of antibodies generated by previous Zika infection on the clinical outcomes of dengue infection.Methodology/principal findings
We enrolled 1,043 laboratory confirmed dengue patients and investigated their prior infection to Zika or dengue. Severe forms of dengue disease were more frequent in patients with previous Zika infection, but not in those previously exposed to dengue.Conclusions/significance
Our findings suggest that previous Zika infection may represent a risk factor for subsequent severe dengue disease, but we did not find evidence of antibody-dependent enhancement (higher viral titer or pro-inflammatory cytokine overexpression) contributing to exacerbation of the subsequent dengue infection.Free full text
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/156299600
Article citations
Modelling the mechanisms of antibody mixtures in viral infections: the cases of sequential homologous and heterologous dengue infections.
J R Soc Interface, 21(219):20240182, 16 Oct 2024
Cited by: 0 articles | PMID: 39406340
Molecular surveillance for dengue serotypes among the population living in Moyen-Ogooué province, Gabon; evidence of the presence of dengue serotype 1.
Virol J, 21(1):141, 20 Jun 2024
Cited by: 0 articles | PMID: 38902719 | PMCID: PMC11191199
Continuing development of vaccines and monoclonal antibodies against Zika virus.
NPJ Vaccines, 9(1):91, 24 May 2024
Cited by: 0 articles | PMID: 38789469 | PMCID: PMC11126562
Data
Data behind the article
This data has been text mined from the article, or deposited into data resources.
Genes & Proteins
- (1 citation) UniProt - P33478
Nucleotide Sequences (4)
- (1 citation) ENA - AAA42941
- (1 citation) ENA - AAV31422
- (1 citation) ENA - AMZ03556
- (1 citation) ENA - AAA99437
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term.
Sci Transl Med, 13(614):eabg9478, 06 Oct 2021
Cited by: 23 articles | PMID: 34613812 | PMCID: PMC8693842
Zika Virus Replication in a Mast Cell Model is Augmented by Dengue Virus Antibody-Dependent Enhancement and Features a Selective Immune Mediator Secretory Profile.
Microbiol Spectr, 10(4):e0177222, 05 Jul 2022
Cited by: 1 article | PMID: 35862953 | PMCID: PMC9431662
Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Front Immunol, 9:597, 23 Apr 2018
Cited by: 66 articles | PMID: 29740424 | PMCID: PMC5925603
Review Free full text in Europe PMC
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection.
BMC Infect Dis, 21(1):749, 04 Aug 2021
Cited by: 8 articles | PMID: 34348665 | PMCID: PMC8334327
Funding
Funders who supported this work.
CNPq
CREID
Conselho Nacional de Desenvolvimento Científico e Tecnológico (1)
Grant ID: 465425/2014-3
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (1)
Grant ID: U01AI151807
Fundação de Amparo à Pesquisa do Estado da Bahia (1)
Grant ID: 022/03645-1
Fundação de Amparo à Pesquisa do Estado de São Paulo (2)
Grant ID: 2018/17647-0
Grant ID: 2022/09229-0
INCT (1)
Grant ID: 405786/2022-0
NIAID NIH HHS (1)
Grant ID: U01 AI151807